InsiderTrades

Form 4 for MRNA Moderna

Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001127602-23-003346 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-03 2023-02-01+ MRNA Bancel Stephane CEO, Dir S - Sale+OE $172.16 -80.0K 5.44M -1% -$13.77M
DM 2023-02-03 2023-02-01+ MRNA Bancel Stephane CEO, Dir M - OptEx $0.99 +80.0K 5.45M +1% +$79.2K
DM 2023-02-03 2023-02-01+ MRNA Bancel Stephane CEO, Dir M - OptEx $0.00 -80.0K 1.63M -5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-01 S D 1,957 $173.03 5,419,146 D — — (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.61 to $173.45. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
2 Common Common Stock 2023-02-02 S D 15,790 $175.03 5,413,395 D — — (F14) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.62 to $175.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
3 Common Common Stock 2023-02-02 S D 10,263 $174.25 5,429,185 D — — (F13) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.60 to $174.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
4 Common Common Stock 2023-02-01 M A 40,000 $0.99 5,451,946 D — —
5 Common Common Stock 2023-02-01 S D 5,848 $167.97 5,446,098 D — — (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.32 to $168.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
6 Common Common Stock 2023-02-01 S D 16,742 $168.75 5,429,356 D — — (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.33 to $169.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
7 Common Common Stock 2023-02-01 S D 6,024 $169.85 5,423,332 D — — (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.35 to $170.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
8 Common Common Stock 2023-02-01 S D 1,629 $170.67 5,421,703 D — — (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.40 to $171.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
9 Common Common Stock 2023-02-01 S D 600 $171.89 5,421,103 D — — (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.57 to $172.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
10 Common Common Stock 2023-02-02 S D 1,449 $175.79 5,411,946 D — — (F15) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.64 to $176.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
11 Common Common Stock 2023-02-01 S D 2,503 $174.21 5,416,643 D — — (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.67 to $174.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
12 Common Common Stock 2023-02-01 S D 4,697 $174.82 5,411,946 D — — (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.68 to $175.63. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
13 Common Common Stock 2023-02-02 M A 40,000 $0.99 5,451,946 D — —
14 Common Common Stock 2023-02-02 S D 2,001 $171.11 5,449,945 D — — (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.52 to $171.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
15 Common Common Stock 2023-02-02 S D 1,589 $172.04 5,448,356 D — — (F11) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.54 to $172.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
16 Common Common Stock 2023-02-02 S D 8,908 $173.19 5,439,448 D — — (F12) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.55 to $173.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
17 Derivative Stock Option (Right to Buy) 2023-02-01 M D 40,000 $0.00 1,667,155 D $0.99 · — to 2023-08-19 40,000 Common Stock (F18) This option is fully vested and exercisable.
18 Derivative Stock Option (Right to Buy) 2023-02-02 M D 40,000 $0.00 1,627,155 D $0.99 · — to 2023-08-19 40,000 Common Stock (F18) This option is fully vested and exercisable.